Revision to QTdrugs - Sertindole

December 17, 2020 at 10:05 PM

AZCERT announces that Sertindole, a drug used in the treatment of schizophrenia, has beem moved from the Possible Risk of Torsades de Pointes (TdP) category to the Known Risk of TdP category because of newly available evidence that it is associated with TdP.

Add Pingback

Please add a comment

You must be logged in to leave a reply. Login »